Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) antidepressant licensed in the UK for treating depression and obsessive-compulsive disorder. Whilst effective for mental health conditions, fluvoxamine can cause sexual side effects, including erectile dysfunction, which affects a significant proportion of men taking SSRIs. Understanding whether fluvoxamine causes erectile dysfunction, why this occurs, and how it can be managed is essential for maintaining both mental health treatment and quality of life. This article explores the relationship between fluvoxamine and erectile function, the underlying mechanisms, and practical management strategies available through your GP.
Summary: Fluvoxamine, an SSRI antidepressant, can cause erectile dysfunction as a recognised side effect by increasing serotonin levels, which may inhibit dopamine and noradrenaline pathways essential for sexual arousal and erectile function.
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) antidepressant licensed in the UK for the treatment of depression and obsessive-compulsive disorder (OCD). It is marketed under the brand name Faverin, though generic versions are also available. As with other SSRIs, fluvoxamine works by increasing the availability of serotonin in the brain, a neurotransmitter that plays a crucial role in regulating mood, anxiety, and emotional wellbeing.
The mechanism of action involves blocking the reuptake of serotonin at the presynaptic neurone, thereby prolonging its activity in the synaptic cleft. This enhanced serotonergic transmission is thought to alleviate symptoms of depression and anxiety over time, typically requiring several weeks of treatment before therapeutic benefits become apparent. Fluvoxamine is generally well-tolerated, but like all medications, it can cause side effects.
Common side effects of fluvoxamine include:
Nausea and gastrointestinal disturbance
Headache and dizziness
Drowsiness or insomnia
Sweating
Sexual dysfunction, including erectile difficulties
Sexual side effects are recognised as one of the more troublesome adverse effects of SSRI therapy, affecting a significant proportion of patients. These effects can include reduced libido, delayed ejaculation, anorgasmia, and erectile dysfunction. In some cases, sexual dysfunction may persist after stopping treatment, as highlighted in MHRA safety updates. Understanding the relationship between fluvoxamine and sexual function is important for both patients and healthcare professionals, as these side effects can significantly impact quality of life and treatment adherence. If you are experiencing sexual difficulties whilst taking fluvoxamine, it is essential to discuss this openly with your GP rather than discontinuing treatment abruptly, as sudden cessation can lead to withdrawal symptoms.
Sexual dysfunction is a well-documented side effect of SSRI antidepressants, with research suggesting that a substantial proportion of patients may experience some form of sexual difficulty during treatment. The reported rates vary widely depending on study methodology, patient populations, and whether side effects are spontaneously reported or systematically assessed. Erectile dysfunction specifically affects a significant number of men taking SSRIs, though precise figures for fluvoxamine alone are difficult to establish.
The mechanism by which fluvoxamine and other SSRIs cause sexual side effects is likely multifaceted, though several hypotheses exist. Elevated serotonin levels may inhibit sexual function through several pathways. Serotonin is thought to have an inhibitory effect on dopamine and noradrenaline pathways, both of which are important for sexual arousal and erectile function. Some research suggests that increased serotonergic activity might stimulate prolactin release from the pituitary gland, and elevated prolactin levels are associated with reduced libido and erectile difficulties.
There are also hypotheses that SSRIs may affect nitric oxide pathways, which are crucial for achieving and maintaining an erection. Nitric oxide is a key mediator of smooth muscle relaxation in the corpus cavernosum of the penis, allowing increased blood flow necessary for erection. The exact mechanisms remain under investigation.
It is important to note that depression and anxiety themselves can significantly impair sexual function, making it sometimes difficult to distinguish between symptoms of the underlying condition and medication side effects. Factors that may contribute to erectile dysfunction include:
The underlying mental health condition
Medication effects on neurotransmitter systems
Psychological factors such as performance anxiety
Concurrent physical health conditions (cardiovascular disease, diabetes)
Other medications (beta-blockers, thiazide diuretics, antipsychotics)
Lifestyle factors (alcohol, smoking, recreational drugs)
Hormonal imbalances (low testosterone, thyroid disorders)
A thorough assessment by your GP can help identify the most likely cause and guide appropriate management.
If you are experiencing erectile dysfunction whilst taking fluvoxamine, there are several management strategies that may be considered in consultation with your GP. It is crucial never to stop or alter your medication without medical supervision, as this can lead to relapse of your mental health condition or cause discontinuation symptoms.
One approach is to allow more time for adjustment, as some sexual side effects may diminish after the first few weeks or months of treatment as your body adapts to the medication. However, if symptoms persist or are significantly affecting your quality of life, your GP may discuss alternative strategies.
Potential management options include:
Dose adjustment: In some cases, reducing the dose of fluvoxamine may alleviate sexual side effects whilst maintaining therapeutic benefit for your mental health condition. This must be done gradually and under medical supervision.
Medication switching: Your doctor may consider switching to an alternative antidepressant with a lower risk of sexual side effects. Options might include mirtazapine, moclobemide, or vortioxetine (which NICE has approved for treating major depressive episodes), though the choice depends on your individual circumstances and the condition being treated.
Adjunctive treatments: Phosphodiesterase-5 (PDE-5) inhibitors such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra) may be prescribed to help manage erectile dysfunction. These medications require careful consideration:
Lower starting doses may be appropriate with fluvoxamine, as it inhibits certain liver enzymes (CYP1A2, CYP3A4, CYP2C19) that metabolise these medications
Psychological support: Cognitive behavioural therapy (CBT) or psychosexual counselling may help address any psychological factors contributing to sexual difficulties.
Your GP may also investigate other potential causes of erectile dysfunction, including cardiovascular disease, diabetes, hormonal imbalances, or other medications. This might involve checking your blood pressure, lipid profile, blood glucose/HbA1c, and morning testosterone levels. NICE guidance emphasises the importance of a holistic approach to managing sexual dysfunction, addressing both physical and psychological factors.
If treatments are unsuccessful or there are concerns about underlying causes, your GP may refer you to a specialist urology or sexual health service.
Sexual side effects from antidepressants are common but often underreported, as many patients feel embarrassed or uncomfortable discussing these issues. However, open communication with your GP is essential for optimising your treatment and maintaining your quality of life. You should arrange to speak with your doctor if:
You develop new erectile difficulties after starting fluvoxamine
Sexual side effects are causing significant distress or affecting your relationship
You are considering stopping your medication due to sexual problems
Sexual dysfunction is not improving after several months of treatment
You have concerns about other potential causes of erectile difficulties
Your GP is accustomed to discussing sexual health matters and will approach the conversation professionally and confidentially. They will likely ask about the timing of symptoms, their severity, and their impact on your life. They may also enquire about other aspects of your health, including cardiovascular risk factors, as erectile dysfunction can sometimes be an early indicator of underlying health conditions such as diabetes or heart disease.
It is particularly important to seek medical advice rather than discontinuing fluvoxamine abruptly. Sudden cessation of SSRIs can lead to discontinuation syndrome, characterised by symptoms such as dizziness, nausea, headache, anxiety, and flu-like symptoms. If a change in medication is appropriate, your GP will create a plan to taper your current medication gradually whilst potentially introducing an alternative.
When to seek urgent medical attention:
Whilst erectile dysfunction itself is not a medical emergency, you should attend A&E immediately if you experience a painful erection lasting more than four hours (priapism), particularly if you are taking additional medications for erectile dysfunction alongside fluvoxamine. This is a medical emergency requiring immediate treatment.
If you experience thoughts of self-harm or significant worsening of your mental health, contact your local NHS mental health crisis team, call NHS 111, or in an emergency, call 999.
Remember that effective treatment for depression and anxiety is essential for your overall wellbeing, and sexual side effects, whilst troublesome, can often be successfully managed without compromising your mental health treatment. Your GP can work with you to find the most appropriate balance between managing your mental health condition and maintaining your sexual function and quality of life.
If you believe you have experienced a side effect from fluvoxamine, you can report it through the MHRA Yellow Card Scheme, which helps monitor medication safety.
Whilst most sexual side effects from fluvoxamine resolve after stopping treatment, the MHRA has highlighted that in some cases sexual dysfunction may persist. If you experience persistent erectile difficulties, discuss this with your GP for appropriate assessment and management.
Some sexual side effects may diminish after the first few weeks or months as your body adapts to fluvoxamine. If symptoms persist or significantly affect your quality of life, consult your GP to discuss management strategies such as dose adjustment or alternative treatments.
PDE-5 inhibitors like sildenafil (Viagra) may be prescribed for erectile dysfunction whilst taking fluvoxamine, but require careful consideration. Fluvoxamine inhibits liver enzymes that metabolise these medications, so lower starting doses may be appropriate, and your GP must assess cardiovascular risk and check for contraindications before prescribing.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript